Optimvia, a biotechnology company specializing in engineering enzymes and their cofactors to synthesize complex therapeutic molecules, and Ginkgo Bioworks, the leading horizontal platform for...
REGENXBIO Inc. announced the clearance of its Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) to evaluate RGX-202,...
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, announced the acquisition of intellectual property rights from the...
Eat Well Investment Group Inc., is pleased to announce that it’s majority-owned portfolio company, Amara Organic Foods (“Amara”), one of the fastest-growing baby food...
